A discussion on COVID-19 in neurodegenerative diseases.
Dates and Times
Start: 2/26/2021 8:00 AM
End: 2/26/2021 9:00 AM
- To review data on vulnerability to SARS-CoV-2 infection amongst patients with Parkinson's and Alzheimer's disease.
- To discuss disease-specific factors impacting the course and outcome of COVID-19 in Parkinson's and Alzheimer's disease.
- To familiarize the audience with speculations regarding risk of neurodegeneration following COVID-19.
The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.